Version: 1.50 | Cost: Entirely Free
|Category:||Irritable Bowel Syndrome|
|Developer:||Bold Health Limited|
It was assessed as a Level 4 App. These Apps can be focused on general health or specific conditions and contain advanced and complex features that are subject to formal regulation. Where they collect data we assess their data use policies and compliance with relevant standards. Because they are health focused we also assess their compliance in the Clinical Assurance as well as the User Experience domains.
This App does collect data and it is therefore assessed and scored based on its performance in all the sections of our review.
We have identified that this App provides the following key features
This review area looks at what information an App collects from users, what it does with that information and how secure is its handling of that data. For some Apps this is only a minor issue as they don’t gather much information. Other Apps can gather lots of very personal and sensitive information and for these it is important to know how they go about handling this.
The data collected about users is/ isn't capable of identifying that it relates to them.
The type of data that it collects is classified as sensitive data.
(Identifiable and Sensitive) - Because of the type of data that this App collects it is particularly important that the App takes the security and privacy of that data seriously and only enables others to see or share this information if the user has expressly consented to this.
The App does state that it won't share user data in any way with other people without the user's consent.
The App does allow users to share information in the App with other Apps, systems, organisations or users.
The App does encrypt the information it collects to make it safe from other people as it is transferred from the App.
The App does encrypt the information it collects to make it safe from other people as it is retained by the the developer.
This review area looks at what evidence there is that there is a suitably qualified professional or organisation behind the App or that it has been endorsed, accredited or underwritten by such an individual or organisation. It also assesses what evidence there is around user testing and what evidence there is that supports the effectiveness of the App in terms of claimed health benefits. The higher the Level of the App and the more sophisticated its functions, the more crucial this becomes.
It was clear from our review that a suitably qualified professional or organisation was involved in the Apps development.
It was clear from our review how regularly the advice and guidance given by the App was reviewed and updated by relevant professionals.
It was clear from our review that the App had been involved in any clinical trials or similar testing to demonstrate its 'real world' effectiveness.
This app is a medical device and has a CE mark.
This Review Area looks at how an App has been designed to support the overall user experience. This includes its availability on both primary platforms, how customisable the App is, how well it caters for end users with different capabilities and needs – such as visual or other impairments – how content is managed, how well supported the App is and what it costs. This area also looks at overall User Review scores from both platforms.
It wasclear from our review that the App had been through end user testing as part of its design and development.
The App does provide customisable features.
The App does provide support for users with poor sight.
The App does provide support for users with hearing difficulties.
The App doesn't appear to have a clear approach to dealing with user issues.
The App is entirely free to use.
We evaluate more apps than anyone, so that you can be aware of the good and bad.
Any score below 65% would indicate that an App has some issues that users should investigate further prior to using this App.
Scores below 45% indicate that an App has considerable issues or challenges and in its current form is potentially unhelpful or unsafe.